MIT Sloan Management Review Article on The Business Case for Quantum Computing

Imagine that a pharmaceutical company was able to cut the research time for innovative drugs by an order of magnitude. It could expand its development pipeline, hit fewer dead ends, and bring cures and treatments to market much faster, to the benefit of millions of people around the world.

Or imagine that a logistics company could dynamically manage the routes for its fleet of thousands of trucks. It could not only take a mind-numbing range of variables into account and adjust quickly as opportunities or constraints arose; it could also get fresher products to store shelves faster and prevent tons of carbon emissions every year.

About the Author

Francesco Bova is an associate professor at the Rotman School of Management at the University of Toronto. Avi Goldfarb is the Rotman Chair in Artificial Intelligence and Healthcare at the Rotman School of Management. Roger Melko is a professor in the Department of Physics & Astronomy at the University of Waterloo and an associate faculty member at the Perimeter Institute for Theoretical Physics.

Learn more about MIT SMR.